This inventor holds 5 USPTO granted patents and 11 published patent applications. Top assignees: Shanghai Cell Therapy Group Co., Ltd., Shanghai Cell Therapy Group Co., Ltd., Shanghai Cell Therapy Research Institute. Active years: 2009-2026.
Company Filing History:
Years Active: 2009-2026
Title: Innovations in Cancer Therapy: The Contributions of Qijun Qian
Introduction
Qijun Qian is an esteemed inventor based in Shanghai, China, with a remarkable portfolio that includes three patents. His innovative work primarily focuses on advancements in cancer therapy, particularly through the development of transgenic cells and recombinant viruses designed to improve treatment efficacy.
Latest Patents
Among his recent patents, one highlights the creation of a killer cell capable of efficiently and stably expressing antibodies for medical applications. This transgenic killer cell integrates a genome with a coding sequence representing a human Fc antibody section, along with an expression cassette containing a chimeric antigen receptor or an inhibitory or agonistic antibody. This invention also includes a pharmaceutical composition that incorporates the transgenic killer cell, showcasing versatile clinical uses.
Another significant patent by Qijun Qian involves a recombinant virus designed to carry an intact tumor-therapeutic antibody featuring human constant regions. This recombinant virus is engineered to express a full-length antibody targeting tumors, effectively inhibiting their growth and metastasis. Such advancements demonstrate Qian's commitment to pioneer solutions in the fight against cancer.
Career Highlights
Qijun Qian's career is marked by his groundbreaking research at the Shanghai Cell Therapy Research Institute, where he has contributed to pivotal innovations in cellular therapy. His work has not only advanced scientific knowledge but has also opened new avenues for clinical applications in oncology. The distinctive nature of Qian's inventions has firmly established him as a notable figure in the field of cancer treatment.
Collaborations
Throughout his career, Qijun Qian has collaborated with distinguished professionals such as Mengchao Wu and Shuntong Shan. These collaborations have led to significant breakthroughs and fostered a dynamic research environment that encourages innovation and the exchange of ideas among experts.
Conclusion
Qijun Qian’s contributions to the field of cancer therapy through his patented inventions represent a crucial step forward in medical science. His dedication to developing effective treatment strategies, exemplified by his innovative killer cells and recombinant viruses, promises to enhance patient outcomes and transform therapeutic approaches in oncology. As he continues to explore new frontiers in research, Qian's work is sure to have a lasting impact on the medical community and the patients it serves.